The present status and direction of prevention, treatment and research on cerebrovascular diseases in China

Chinese Journal of Contemporary Neurology and Neurosurgery

Volumn 11, Issue 2, 2011, Pages 134-137

  Wang, Wenzhi ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CEREBROVASCULAR DISEASE; CHINA; EDITORIAL; HUMAN; MEDICAL RESEARCH;

EID: 79959631604     PISSN: 16726731     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-6731.2011.02.003     Document Type: Editorial

References (13)

1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke, 1991, 22:983-988.
2. Puska P, Tuomilehto J, Nissinen A, et al. The North Karelia Project: 15 years of community - based prevention of coronary heart disease. Ann Med, 1989, 21:169-173. (Pubitemid 19177416)
3. Fortmann SP, Flora JA, Winkleby MA, et al. Community intervention trials: reflections on the Stanford Five-City Project experience. Am J Epidemiol, 1995, 142:576-586.
4. Wang WZ, Jiang B, Wu SP, et al. Change in stroke incidence from a population - based intervention trial in three urban communities in China. Neuroepidemiology, 2007, 28:155-161. (Pubitemid 47344337)
5. Huang Y, Cheng Y, Wu J, et al. Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study. Lancet Neurol, 2008, 7:494-499.
6. Rothwell PM, Giles MF, Chandratheva A, et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet, 2007, 370:1432-1442. (Pubitemid 47576154)
7. Anderson CS, Huang Y, Wang JG, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol, 2008, 7: 391-399.